Earnings History Data for Annovis Bio, Inc. (ANVS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Annovis Bio, Inc.
Annovis Bio Inc. is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer's disease, Parkinson's disease and Alzheimer's in Down Syndrome. Annovis Bio Inc. is headquartered in Berwyn, Pennsylvania.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29-03-2024 | PM | ANVS | Annovis Bio, Inc. | 123.46 | -1.09 | -1.35 | -0.38 | Annovis Bio GAAP EPS of -$6.23 misses by $3.15 [4/2/2024 7:37 AM] |
11.20 | -0.76 (-6.35%) |
12.10 | 0.14 (1.17%) |
5.42 - 22.49 | 189,695 | 430,000 | 2,396 | ||
| 08-11-2023 | AH | ANVS | Annovis Bio | 57.00 | -1.63 | -1.10 | 0.00 | Annovis Bio reports Q3 results [11/8/2023 5:36 PM] |
5.80 | 0.25 (4.50%) |
6.25 | 0.70 (12.61%) |
5.42 - 23.89 | 90,152 | 100,000 | 1,704 | ||
| 15-08-2023 | PM | ANVS | Annovis Bio, Inc. | 118.51 | -1.07 | -1.14 | -1.07 | Annovis Bio reports Q2 results [8/15/2023 7:27 AM] |
12.70 | -0.46 (-3.50%) |
13.17 | 0.01 (0.08%) |
10.14 - 23.91 | 44,840 | 20,000 | 106 | ||
| 11-05-2023 | PM | ANVS | Annovis Bio, Inc. | 121.61 | -1.19 | -0.85 | -0.72 | Annovis Bio reports Q1 results [5/11/2023 9:19 AM] |
14.98 | 0.02 (0.13%) |
14.99 | 0.19 (1.28%) |
8.39 - 23.91 | 32,919 | 30,000 | 100 | ||
| 03-04-2023 | PM | Before the open (Apr 3) |
ANVS | Annovis Bio | 164.00 | -0.38 | -1.15 | 0.00 | Annovis Bio reports Q4 results [4/3/2023 7:35 AM] |
11.99 | -3.42 (-22.19%) |
13.07 | -2.34 (-15.18%) |
8.39 - 23.91 | 457,355 | 140,000 | 34,091 | |
| 08-11-2022 | AH | ANVS | Annovis Bio | 102.00 | -0.93 | -1.17 | 0.00 | Annovis Bio GAAP EPS of -$0.93 beats by $0.08 [11/8/2022 5:47 PM] |
11.85 | -0.30 (-2.47%) |
12.13 | -0.35 (-2.80%) |
8.39 - 37.60 | 17,162 | 20,000 | 161 | ||